공간 유전체학 및 전사체학 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Spatial Genomics & Transcriptomics Market size is expected to reach USD 1826.96 Million in 2034 from USD 491.35 Million (2025) growing at a CAGR of 15.71% during 2026-2034.

The Global Spatial Genomics & Transcriptomics Market has gained rapid momentum due to its ability to analyze gene expression within the spatial context of tissues. This technology is transforming biomedical research, especially in oncology, neuroscience, and immunology. Increasing research funding and rising interest in precision medicine are contributing to strong market growth worldwide.

The key drivers include advancements in sequencing technologies, improved imaging techniques, and the growing need for better disease understanding at the cellular level. Pharmaceutical and biotechnology companies are increasingly adopting spatial analysis tools for drug discovery and biomarker identification. The integration of artificial intelligence and data analytics is further enhancing the accuracy and value of spatial genomic insights.

Future prospects for this market remain highly promising as clinical applications expand. As technology becomes more cost-effective and standardized, its adoption is expected to grow beyond research laboratories into clinical diagnostics. Continued innovation and collaboration between research institutions and biotech companies will likely accelerate market expansion over the next decade.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Spatial Transcriptomics Technique

• Spatial Transcriptomics
• Immunohistochemistry (IHC)
• Fluorescent In-situ Hybridization (FISH)
• Sequencing
• In-situ Capturing
• In-silico Construction
• Microscopy-based RNA Imaging Techniques
• Transcriptome In-vivo Analysis (TIVA)
• Spatial Genomics Analysis
• Fluorescence In-situ Sequencing
• Fluorescence Microscopy
• Other Techniques

By Product

• Consumables
• Instruments
• Software
• Imaging Tools
• Bioinformatics Tools
• Storage and Management Databases

By Application

• Translational Research
• Drug Discovery & Development

By End User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes

COMPANIES PROFILED

• Natera Inc, 10x Genomics, Dovetail Genomics, Illumina Inc, S2 Genomics Inc, NanoString Technologies Inc, Seven Bridges Genomics, Horizon Discovery Group plc, Cartana AB, Readcoor Inc, BioTechne Corporation, BioRad Laboratories Inc, Danahar Corporation, BioSpyder Technologies Inc, Lunaphore Technologies SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY SPATIAL TRANSCRIPTOMICS TECHNIQUE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Spatial Transcriptomics Technique
• 4.2. Spatial Transcriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunohistochemistry (IHC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fluorescent In-situ Hybridization (FISH) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. In-situ Capturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. In-silico Construction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Microscopy-based RNA Imaging Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Transcriptome In-vivo Analysis (TIVA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Spatial Genomics Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Fluorescence In-situ Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Fluorescence Microscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.13. Other Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Imaging Tools Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Bioinformatics Tools Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Storage and Management Databases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Translational Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Spatial Transcriptomics Technique
  • 8.2.2 By Product
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Spatial Transcriptomics Technique
  • 8.3.2 By Product
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Spatial Transcriptomics Technique
  • 8.4.2 By Product
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Spatial Transcriptomics Technique
  • 8.5.2 By Product
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Spatial Transcriptomics Technique
  • 8.6.2 By Product
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Natera Inc
  • 10.2.2 10x Genomics
  • 10.2.3 Dovetail Genomics
  • 10.2.4 Illumina Inc
  • 10.2.5 S2 Genomics Inc
  • 10.2.6 NanoString Technologies Inc
  • 10.2.7 Seven Bridges Genomics
  • 10.2.8 Horizon Discovery Group Plc
  • 10.2.9 Cartana AB
  • 10.2.10 Readcoor Inc
  • 10.2.11 Bio-Techne Corporation
  • 10.2.12 Bio-Rad Laboratories Inc
  • 10.2.13 Danahar Corporation
  • 10.2.14 BioSpyder Technologies Inc
  • 10.2.15 Lunaphore Technologies SA